Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Gold R, Giovannoni G, Selmaj K, Havrdova E, et al. Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial. Lancet 2013 Apr 3. pii: S0140-6736(12)62190.
PMID: 23562009


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016